Christine M McDonald1, Karim P Manji2, Kerri Gosselin1, Hao Tran3, Enju Liu4, Rodrick Kisenge2, Said Aboud5, Wafaie W Fawzi6, Andrew T Gewirtz3, Christopher P Duggan7. 1. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA; 2. Pediatrics and Child Health and. 3. Institute for Biomedical Sciences, Georgia State University, Atlanta, GA; and. 4. Departments of Global Health and Population. 5. Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; 6. Departments of Global Health and Population, Epidemiology, and Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA. 7. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA; Departments of Global Health and Population, Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA christopher.duggan@childrens.harvard.edu.
Abstract
BACKGROUND: Antibodies to LPS and flagellin have been described as indirect measures of increased gastrointestinal permeability and may be markers of environmental enteric dysfunction (EED), which is a condition associated with poor child growth. OBJECTIVE: We assessed whether LPS- and flagellin-specific immunoglobulin (Ig) concentrations were associated with poor growth in young Tanzanian children at risk of EED. DESIGN: Blood samples were obtained from 590 children at 6 wk, 6 mo, and 12 mo of age. Serum LPS- and flagellin-specific Ig concentrations (IgA and IgG) were measured with the use of an ELISA. Growth was measured on a monthly basis for 18 mo. RESULTS: Anti-LPS and anti-flagellin IgA and IgG concentrations increased over the first year of life and were higher than concentrations (measured at 9 mo of age) in healthy controls. Children with anti-flagellin IgA, anti-LPS IgA, anti-flagellin IgG, and anti-LPS IgG concentrations in the highest quartile at 6 wk of age were 2.02 (95% CI: 1.11, 3.67), 1.84 (95% CI: 1.03, 3.27), 1.94 (95% CI: 1.04, 3.62), and 2.31 (95% CI: 1.25, 4.27) times, respectively, more likely to become underweight (weight-for-age z score <-2) after adjustment for covariates (P-trend < 0.05) than were children with Ig concentrations in the lowest quartile. Children with increased concentrations of anti-flagellin IgA were also more likely to become wasted; however, there was no association between any of the markers and subsequent stunting. CONCLUSION: Serologic measures of increased intestinal permeability to bacterial components are associated with subsequent poor growth and could help identify children who may benefit most from preventive interventions. This trial was registered at clinicaltrials.gov as NCT00421668.
BACKGROUND: Antibodies to LPS and flagellin have been described as indirect measures of increased gastrointestinal permeability and may be markers of environmental enteric dysfunction (EED), which is a condition associated with poor child growth. OBJECTIVE: We assessed whether LPS- and flagellin-specific immunoglobulin (Ig) concentrations were associated with poor growth in young Tanzanian children at risk of EED. DESIGN: Blood samples were obtained from 590 children at 6 wk, 6 mo, and 12 mo of age. Serum LPS- and flagellin-specific Ig concentrations (IgA and IgG) were measured with the use of an ELISA. Growth was measured on a monthly basis for 18 mo. RESULTS: Anti-LPS and anti-flagellin IgA and IgG concentrations increased over the first year of life and were higher than concentrations (measured at 9 mo of age) in healthy controls. Children with anti-flagellin IgA, anti-LPS IgA, anti-flagellin IgG, and anti-LPS IgG concentrations in the highest quartile at 6 wk of age were 2.02 (95% CI: 1.11, 3.67), 1.84 (95% CI: 1.03, 3.27), 1.94 (95% CI: 1.04, 3.62), and 2.31 (95% CI: 1.25, 4.27) times, respectively, more likely to become underweight (weight-for-age z score <-2) after adjustment for covariates (P-trend < 0.05) than were children with Ig concentrations in the lowest quartile. Children with increased concentrations of anti-flagellin IgA were also more likely to become wasted; however, there was no association between any of the markers and subsequent stunting. CONCLUSION: Serologic measures of increased intestinal permeability to bacterial components are associated with subsequent poor growth and could help identify children who may benefit most from preventive interventions. This trial was registered at clinicaltrials.gov as NCT00421668.
Authors: Stephan R Targan; Carol J Landers; Huiying Yang; Michael J Lodes; Yingzi Cong; Konstantinos A Papadakis; Eric Vasiliauskas; Charles O Elson; Robert M Hershberg Journal: Gastroenterology Date: 2005-06 Impact factor: 22.682
Authors: Christine M McDonald; Karim P Manji; Rodrick Kisenge; Said Aboud; Donna Spiegelman; Wafaie W Fawzi; Christopher P Duggan Journal: J Nutr Date: 2015-07-22 Impact factor: 4.798
Authors: A Dlugosz; P Nowak; M D'Amato; G Mohammadian Kermani; J Nyström; S Abdurahman; G Lindberg Journal: Neurogastroenterol Motil Date: 2015-09-21 Impact factor: 3.598
Authors: Gerald T Keusch; Irwin H Rosenberg; Donna M Denno; Christopher Duggan; Richard L Guerrant; James V Lavery; Philip I Tarr; Honorine D Ward; Robert E Black; James P Nataro; Edward T Ryan; Zulfiqar A Bhutta; Hoosen Coovadia; Aldo Lima; Balakrishnan Ramakrishna; Anita K M Zaidi; Deborah C Hay Burgess; Thomas Brewer Journal: Food Nutr Bull Date: 2013-09 Impact factor: 2.069
Authors: Donna M Denno; Kelley VanBuskirk; Zakia C Nelson; Christine A Musser; Deborah C Hay Burgess; Phillip I Tarr Journal: Clin Infect Dis Date: 2014-11-01 Impact factor: 9.079
Authors: C M McDonald; R Kupka; K P Manji; J Okuma; R J Bosch; S Aboud; R Kisenge; D Spiegelman; W W Fawzi; C P Duggan Journal: Eur J Clin Nutr Date: 2012-10-03 Impact factor: 4.016
Authors: Herlice do Nascimento Veras; Pedro H Q S Medeiros; Samilly A Ribeiro; Thiago M Freitas; Ana K S Santos; Marília S M G Amaral; Mariana D Bona; Alexandre Havt; Ila F N Lima; Noélia L Lima; Alessandra Di Moura; Álvaro M Leite; Alberto M Soares; José Q Filho; Richard L Guerrant; Aldo A M Lima Journal: Eur J Clin Microbiol Infect Dis Date: 2018-07-26 Impact factor: 3.267
Authors: Christopher R Sudfeld; Karim P Manji; Emily R Smith; Said Aboud; Rodrick Kisenge; Wafaie W Fawzi; Christopher P Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2017-10 Impact factor: 2.839
Authors: Lindsey M Locks; Ramadhani S Mwiru; Expeditho Mtisi; Karim P Manji; Christine M McDonald; Enju Liu; Roland Kupka; Rodrick Kisenge; Said Aboud; Kerri Gosselin; Matthew Gillman; Andrew T Gewirtz; Wafaie W Fawzi; Christopher P Duggan Journal: J Pediatr Date: 2017-05-09 Impact factor: 4.406
Authors: Sana Syed; Najeeha T Iqbal; Kamran Sadiq; Jennie Z Ma; Tauseef Akhund; Wenjun Xin; Sean R Moore; Enju Liu; Shahida Qureshi; Kerri Gosselin; Andrew Gewirtz; Christopher P Duggan; S Asad Ali Journal: PLoS One Date: 2018-03-06 Impact factor: 3.240
Authors: Jacqueline M Lauer; Christopher P Duggan; Lynne M Ausman; Jeffrey K Griffiths; Patrick Webb; Edgar Agaba; Nathan Nshakira; Hao Q Tran; Andrew T Gewirtz; Shibani Ghosh Journal: Am J Clin Nutr Date: 2018-10-01 Impact factor: 7.045